PTPA and cancer: Toxicity permitting, the combination of a small molecule inhibitor of PP2A and an agent targeting DNA, such as chemotherapy and x-radiation, may provide newer and more effective treatments for a broad spectrum of human cancers despite large differences in their degrees of differentiation and growth rates.